Azithromycin in viral infections
Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of bacterial and mycobacterial infections. Due to an additional range of anti‐viral and anti‐inflammatory properties, it has been given to patients with the coronaviruses SARS‐CoV or MERS‐CoV. It is now being inve...
Príomhchruthaitheoirí: | Oliver, ME, Hinks, TSC |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Wiley
2020
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Azithromycin for mild-to-moderate COVID-19 - Authors' reply
de réir: Hinks, TSC
Foilsithe / Cruthaithe: (2021) -
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
de réir: Lavoie, G, et al.
Foilsithe / Cruthaithe: (2024) -
Study of MAIT cell activation in viral infections in vivo
de réir: Hinks, TSC, et al.
Foilsithe / Cruthaithe: (2019) -
Boosting MAIT cells as immunotherapy: Context is everything
de réir: Hinks, TSC
Foilsithe / Cruthaithe: (2020) -
Azithromycin for mild-to-moderate COVID-19: author's reply
de réir: Hinks, TSC, et al.
Foilsithe / Cruthaithe: (2021)